# China NMPA Drug Inspection - Shanghai Huangxiang Tieli Lantian Pharmaceutical Co., Ltd. - Berberine hydrochloride

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/shanghai-huangxiang-tieli-lantian-pharmaceutical-co-ltd/8e9b6cba-c979-4fb5-ba79-3200bc24850d/
Source feed: China

> China NMPA drug inspection for Shanghai Huangxiang Tieli Lantian Pharmaceutical Co., Ltd. published March 25, 2020. Drug: Berberine hydrochloride. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Drug Quality Bulletin of Guangxi Zhuang Autonomous Region Drug Administration (Issue 1, 2020)
- Company Name: Shanghai Huangxiang Tieli Lantian Pharmaceutical Co., Ltd.
- Publication Date: 2020-03-25
- Drug Name: Berberine hydrochloride
- Inspection Finding: [Characteristics]
- Action Taken: The relevant drug regulatory authorities have been organized to take necessary control measures against drugs that fail to meet the standards and to handle them in accordance with the law.

Company: https://www.globalkeysolutions.net/companies/shanghai-huangxiang-tieli-lantian-pharmaceutical-co-ltd/394bf645-a2d9-4296-91c7-a19583547e38/